Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUCMSC-Secretome as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo
NCT07509242Phase 3Not yet recruiting
- Start
- Mar 2026
- Primary completion
- Jan 2027
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of SM-hUCMSC secretome in nonsegmental vitiligo (NSV). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
SM-hUCMSC secretome
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT07509242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509242.